PTK2 and prostate carcinoma: As numerous FAK activators and downstream signaling molecules are involved in this process, we developed highly migratory sublines of the prostate cancer cell lines PC3 and DU145 by multiple cycles of in vitro selection for cells that had migrated in a modified Boyden chamber (see schema, Fig. 1A).